CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 61 filers reported holding CASI PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $61,000 | -33.7% | 30,000 | 0.0% | 0.00% | – |
Q4 2019 | $92,000 | -8.0% | 30,000 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $100,000 | +4.2% | 30,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $96,000 | +11.6% | 30,000 | 0.0% | 0.00% | – |
Q1 2019 | $86,000 | -28.3% | 30,000 | 0.0% | 0.00% | -100.0% |
Q4 2018 | $120,000 | -14.3% | 30,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $140,000 | -43.1% | 30,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $246,000 | – | 30,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellington Shields & Co., LLC | 896,137 | $4,185,000 | 2.27% |
Wellington Shields Capital Management, LLC | 888,333 | $4,149,000 | 0.67% |
Manatuck Hill Partners, LLC | 15,090 | $70,000 | 0.03% |
IHT Wealth Management, LLC | 10,725 | $50,000 | 0.01% |
Perceptive Advisors | 43,682 | $204,000 | 0.01% |
ALPS ADVISORS INC | 153,234 | $716,000 | 0.01% |
ROYCE & ASSOCIATES LP | 78,742 | $368,000 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 5,863 | $28,000 | 0.00% |
Tower Research Capital LLC (TRC) | 5,974 | $28,000 | 0.00% |
METROPOLITAN LIFE INSURANCE CO/NY | 18,585 | $86,792 | 0.00% |